Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate brachytherapy.

William J Ellis1

  • 1Department of Urology, University of Washington, Seattle, Washington 98195, USA. wjellis@u.washington.edu

Cancer Metastasis Reviews
|December 6, 2002
PubMed
Summary
This summary is machine-generated.

Prostate brachytherapy, a minimally invasive cancer treatment, has advanced significantly with technology. It offers comparable survival rates to other therapies but can cause temporary urinary symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.

JAMA·2024
Same author

Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS Cohort.

Urology practice·2023
Same author

Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.

Nutrition and cancer·2022
Same author

Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.

The Journal of urology·2022
Same author

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.

Cancer medicine·2022
Same author

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.

Cancer·2021
Same journal

HER2 assessment in urothelial carcinoma: standardization challenges and the path forward.

Cancer metastasis reviews·2026
Same journal

Resolving translational challenges in cancer biology through yeast experimental evolution.

Cancer metastasis reviews·2026
Same journal

Spheroids and organoids to study long noncoding RNAs in cancer: how they could replace animal models.

Cancer metastasis reviews·2026
Same journal

Strategies and successes of smoking cessation methods in head and neck cancer patients: a systematic review.

Cancer metastasis reviews·2026
Same journal

The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities.

Cancer metastasis reviews·2026
Same journal

Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progress.

Cancer metastasis reviews·2026
See all related articles

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Prostate brachytherapy has a long history, evolving over nearly a century.
  • Recent technological advancements in imaging, computing, and devices have modernized the technique.
  • Understanding radiobiology principles is crucial for modern prostate brachytherapy.

Purpose of the Study:

  • To review the current status and principles of prostate brachytherapy.
  • To discuss its application in various risk groups of prostate cancer.
  • To highlight treatment outcomes and associated morbidities.

Main Methods:

  • Review of prostate brachytherapy techniques and outcomes.
  • Discussion of treatment stratification based on tumor risk.

Related Experiment Videos

  • Integration of radiobiology principles in treatment planning.

    • Main Results:

    • Brachytherapy can be used as monotherapy for low-risk tumors.
    • Combination therapy with external beam radiation is indicated for high-risk tumors.
    • Disease-free survival rates are comparable to other definitive treatments for localized prostate cancer.

    Conclusions:

    • Prostate brachytherapy is a mainstream treatment for prostate cancer.
    • Short-term morbidities include voiding symptoms.
    • Future research aims to further refine brachytherapy techniques and outcomes.